Rapport Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol: RAPP on Nasdaq
Industry: Pharmaceutical Preparations
Location: 1325 Boylston Street, Suite 401, Boston, MA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+16K	48.5%	$10.14	+$162K
Sells	1	-17K	51.5%	$10.21	-$174K
Net	+1	-1K	-3%		-$11.3K

Rapport Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Third Rock Ventures V, L.P.	10%+ Owner	$80.9M			Jun 10, 2024
ARCH Venture Partners XII, LLC	10%+ Owner	$37.2M			Jun 10, 2024
James Healy	Director	$19.9M			Jul 1, 2024
Abraham Ceesay	Chief Executive Officer, Director	$7.88M			Feb 3, 2025
Steven M. Paul	Director	$4.77M			Jun 6, 2024
David Bredt	Chief Scientific Officer	$4.41M	-$174K	-3.79%	Apr 15, 2025
Krishnaswamy Yeleswaram	Chief Development Officer	$2.9M			Feb 3, 2025
Bradley S. Galer	Chief Medical Officer	$1.97M			Jun 6, 2024
Cheryl Gault	Chief Operating Officer	$1.72M			Mar 3, 2025
Troy Ignelzi	Chief Financial Officer	$99.8K	+$101K		Mar 12, 2025
Wendy B. Young	Director	$61.3K	+$61.3K		Mar 12, 2025
Ramiro Sanchez	Director				Nov 7, 2024
Paul M. Silva	Director				Nov 7, 2024
Robert J. Perez	Director				Nov 7, 2024
John Maraganore	Director				Jun 6, 2024
Jeffrey K. Tong	Director				Jun 6, 2024
Terry-Ann Burrell	Director				Jun 6, 2024
Reid M. Huber	Director				Jun 6, 2024
Jeffrey Sevigny	Chief Medical Officer				Apr 1, 2025

Recent Insider Transactions by Companies or Individuals for Rapport Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.